Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 4,796 | 50,979 | 3,517 | 3,363 | 6,765 |
| Operating Income | -4,796 | -50,979 | -3,517 | -3,363 | -6,765 |
| Interest Expense | 4 | 5 | 0 | 5 | 0 |
| Other Income | 276 | 1,423 | 805 | 2,460 | 3,514 |
| Pre-tax Income | -4,524 | -49,560 | -2,712 | -908 | -3,251 |
| Net Income Continuous | -4,524 | -42,106 | -2,712 | -908 | -3,251 |
| Net Income | $-4,524 | $-42,106 | $-2,712 | $-908 | $-3,251 |
| EPS Basic Total Ops | -961.10 | -15,415.46 | -1,063.69 | -383.36 | -1,799.82 |
| EPS Basic Continuous Ops | -961.32 | -15,425.80 | -1,063.58 | -382.95 | -1,803.43 |
| EPS Diluted Total Ops | -961.10 | -15,415.46 | -1,063.69 | -383.36 | -1,799.82 |
| EPS Diluted Continuous Ops | -961.32 | -15,425.80 | -1,063.58 | -382.95 | -1,803.43 |
| EBITDA(a) | $-4,692 | $-12,102 | $-3,343 | $-3,189 | $-6,628 |